A population-based association study is thought to produce a high false-positive rate due to population stratification. 7, 8 The present work was therefore undertaken to genotype MTHFR in nuclear families consisting of mothers, fathers and affected offspring with schizophrenia. We also attempted to test if the gene coding for cystathionine beta-synthase (CBS), which catalyses the conversion of homocysteine into cysteine, was associated with schizophrenia.
A total of 56 Caucasian nuclear families were investigated in this study. The patients had been diagnosed as having schizophrenia by the psychiatrists who initially treated them. All the subjects gave informed consent that blood samples should be taken. Genomic DNA was extracted from the whole blood samples. The HinfI site in the MTHFR gene was typed using a polymerase chain reaction (PCR) procedure with a pair of primers, 5ЈTGAAGGAGAAGGTGTCTGCGG3Ј and 5ЈAGGACGG TGCGGTGAGAGTG3Ј. The PCR amplification was conducted in a 25-l reaction volume containing 10 mM Tris-HCl (pH 8. and the transmission/ disequilibrium test (TDT), 8 were applied to process the data. In the HHRR test, the allele transmitted independently from parents to offspring was used as a 'case' and that non-transmitted as a 'control'. As shown in Table 1 , the HHRR test revealed a significant difference between transmitted and non-transmitted alleles ( 2 = 7.23, d.f. = 1, P = 0.007). This result suggests that the MTHFR gene may be associated with schizophrenia.
Among these 56 nuclear families, 51 parents were heterozygous and they transmitted 34 A1 and 17 A2 alleles to their affected offspring, respectively. The TDT statistic showed a significant difference ( 2 = 5.67, d.f. = 1, P = 0.017). In contrast, Regland et al and Arinami et al reported that an excess of the A2 allele was found among individuals with schizophrenia or schizophrenia-like psychoses, 4, 5 whereas in the present study we found that the A1 allele was more frequently distributed among schizophrenic patients. Perhaps the C677T mutation itself may not play a role in determining the susceptibility to schizophrenia but serves as a genetic marker indicating a locus for schizophrenia closely linked to the marker locus. Since homocysteinemia may be a risk factor for schizophrenia, 4,9 the contribution of CBS should be taken into account. A polymorphic MspI site has been identified at the 3Ј-untranslated region of the CBS gene. 10 It was used as a genetic marker in this study to test the association between schizophrenia and the CBS gene by following the procedure described by Avramopoulos and coworkers. 10 Neither the TDT nor the HHRR test showed a significant association of the MpsI site with schizophrenia. Moreover, methionine synthase, which is the enzyme for the remethylation of homocysteine into methionine, could be considered as a candidate for the homocysteinemia found in schizophrenia. 9 It would be important to detect the association between the methionine synthase gene and schizophrenia if any genetic markers were identified on its gene locus in future.
